[HTML][HTML] Aggressive pituitary tumors and pituitary carcinomas

SMC De Sousa, AI McCormack - Endotext [Internet], 2022 - ncbi.nlm.nih.gov
Aggressive pituitary tumors (APT) refer to pituitary adenomas exhibiting radiological
invasiveness and an unusually rapid tumor growth rate, or clinically relevant tumor growth …

[HTML][HTML] The epidemiology of aggressive pituitary tumors (and its challenges)

OM Dekkers, N Karavitaki, AM Pereira - Reviews in Endocrine and …, 2020 - Springer
Pituitary tumors are not rare if prevalence rates from autopsy or radiological series are
considered; approximately 0.5% of all pituitary adenomas will come to medical attention …

Definition and diagnosis of aggressive pituitary tumors

L Kasuki, G Raverot - Reviews in Endocrine and Metabolic Disorders, 2020 - Springer
Pituitary adenomas are considered benign tumors, but approximately 10% of them can have
an aggressive behavior and more rarely (0.2%) can present metastasis, being classified as …

Nonfunctioning pituitary adenoma recurrence and its relationship with sex, size, and hormonal immunohistochemical profile

RL Batista, EB Trarbach, MD Marques, VA Cescato… - World neurosurgery, 2018 - Elsevier
Background Tumor recurrence or incomplete resection in nonfunctioning pituitary adenomas
(NFPAs) is relatively common. However, predictive factors of tumor recurrence in NFPAs are …

Non-functioning pituitary adenomas: growth and aggressiveness

KA Øystese, JA Evang, J Bollerslev - Endocrine, 2016 - Springer
Pituitary adenomas (PAs) are common, comprising approximately one third of all intracranial
tumors. Non-functioning pituitary adenomas (NFPAs) are the most common PAs. Although …

[HTML][HTML] Emerging and novel treatments for pituitary tumors

MD Ilie, H Lasolle, G Raverot - Journal of clinical medicine, 2019 - mdpi.com
A subset of pituitary neuroendocrine tumors (PitNETs) have an aggressive behavior,
showing resistance to treatment and/or multiple recurrences in spite of the optimal use of …

Congress of neurological surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary …

J Sheehan, CC Lee, ME Bodach, LM Tumialan… - …, 2016 - journals.lww.com
BACKGROUND: Despite the advancement of microsurgical and endoscopic techniques,
some nonfunctioning pituitary adenomas (NFPAs) can be difficult to cure. Tumor recurrence …

Non-functioning pituitary adenomas

Y Greenman, N Stern - Best practice & research Clinical endocrinology & …, 2009 - Elsevier
Non-functioning pituitary tumours are mostly of gonadotroph cell origin and are devoid of
humoral hypersecretory syndromes. They are usually large at the time of diagnosis …

Long‐term follow‐up of a large prospective cohort of patients with nonfunctioning pituitary adenomas: the outcome of a conservative management policy

MJ Levy, IJ Robertson, N Khalk, S Vitello… - Clinical …, 2018 - Wiley Online Library
Objective To assess the clinical outcome of a strategy of conservative monitoring of patients
with nonfunctioning pituitary adenomas (NFPA) after pituitary surgery and in patients without …

Outcome of nonfunctioning pituitary adenomas that regrow after primary treatment: a study from two large UK centers

M Tampourlou, G Ntali, S Ahmed, W Arlt… - The Journal of …, 2017 - academic.oup.com
Context: Despite the major risk of regrowth of clinically nonfunctioning pituitary adenomas
(CNFAs) after primary treatment, systematic data on the probability of further tumor …